Chen Jing 4
4 · Harvard Apparatus Regenerative Technology, Inc. · Filed Jul 1, 2025
Insider Transaction Report
Form 4
Chen Jing
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-27+18,590→ 18,590 totalExercise: $1.60Exp: 2035-06-27→ Common Stock, par value $0.01 per share (18,590 underlying) - Award
Stock Option (right to buy)
2025-06-27+15,227→ 15,227 totalExercise: $1.60Exp: 2035-06-27→ Common Stock, par value $0.01 per share (15,227 underlying)
Footnotes (2)
- [F1]This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 27, 2025, December 27, 2025, March 27, 2026 and June 27, 2026.
- [F2]This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2025, September 30, 2025 and December 31, 2025.